This inventor holds 2 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2017
Title: David Eric Freund: Innovator in Retinal Disease Detection
Introduction
David Eric Freund is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of retinal disease detection, holding 2 patents that focus on innovative methods for diagnosing and classifying retinal conditions.
Latest Patents
Freund's latest patents include a "System and method for detecting and classifying severity of retinal disease." This method utilizes retinal images to identify key features associated with various retinal diseases and their severity. The process involves receiving and analyzing retinal images, comparing them to reference data, and determining the likelihood of a retinal disease's presence or development.
Another significant patent is the "System and method for automated detection of age-related macular degeneration and other retinal abnormalities." This system employs a retinal scanner connected to a central processing unit (CPU) that analyzes retinal data to detect abnormalities. The CPU executes instructions to identify healthy areas and potential issues within the retinal data.
Career Highlights
David Eric Freund is affiliated with Johns Hopkins University, where he continues to advance research in retinal health. His work has the potential to improve early detection and treatment of retinal diseases, significantly impacting patient outcomes.
Collaborations
Freund collaborates with esteemed colleagues, including Philippe Martin Burlina and Neil M Bressler. Their combined expertise enhances the research and development of innovative solutions in the field of ophthalmology.
Conclusion
David Eric Freund's contributions to retinal disease detection through his patents and collaborations exemplify his commitment to advancing medical technology. His work is paving the way for improved diagnostic methods that can benefit countless individuals facing retinal health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
